共 148 条
Progress in Lipid and Inorganic Nanocarriers for Enhanced Skin Drug Delivery
被引:1
作者:
Albakr, Lamyaa
[1
,2
]
Du, Hongyuan
[3
]
Zhang, Xiyuan
[1
]
Kathuria, Himanshu
[4
]
Anwar-Fadzil, Ahmed Fahmi
[1
]
Wheate, Nial J.
[1
]
Kang, Lifeng
[1
]
机构:
[1] Univ Sydney, Sch Pharm, Fac Med & Hlth, Sydney, NSW 2006, Australia
[2] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh 11451, Saudi Arabia
[3] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Med Genet, Wuhan 430030, Peoples R China
[4] Nusmet Pte Ltd, E Ctr Redhill, 3791 Jalan Bukit Merah, Singapore 159471, Singapore
来源:
ADVANCED NANOBIOMED RESEARCH
|
2024年
/
4卷
/
06期
关键词:
drug delivery;
formulations;
nanocarriers;
nanoparticles;
skin;
topical;
transdermal;
MESOPOROUS SILICA NANOPARTICLES;
POLYMER HYBRID NANOPARTICLES;
IN-VITRO CHARACTERIZATION;
TRANSDERMAL DELIVERY;
TOPICAL DELIVERY;
SILVER NANOPARTICLES;
GOLD NANOPARTICLES;
STATISTICAL OPTIMIZATION;
PERMEATION ENHANCERS;
VESICULAR CARRIER;
D O I:
10.1002/anbr.202400003
中图分类号:
R318 [生物医学工程];
学科分类号:
0831 ;
摘要:
New advancements in nanocarrier technologies are revolutionizing the delivery of drugs through the skin, allowing for precise treatment with better absorption, stability, and bioavailability. This review investigates lipid and inorganic nanocarriers like liposomes, ethosomes, and inorganic nanoparticles and assesses their potential for delivering drugs through the skin. It emphasizes the mechanisms that enable controlled release and deeper skin penetration, which are crucial for ensuring effectiveness in clinical applications. The review synthesizes existing research, acknowledging that only few nanocarriers are successfully deployed in clinical settings. By offering a comprehensive overview, it sheds light on the progress and future obstacles to using nanocarriers for drug delivery through the skin. Nanocarriers for topical and transdermal drug delivery consist of two primary types: lipid and inorganic. The most used are lipid nanocarriers, owing to their biocompatibility and ability to encapsulate a wide range of drugs. Despite the large number of nanocarriers being investigated, only a few have been clinically approved.image (c) 2024 WILEY-VCH GmbH
引用
收藏
页数:24
相关论文